Work

CXCR4 overexpression: An indicator of poor survival and predictor of response to immunotherapy in patients with metastatic colorectal cancer.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.3546

Authors: Sepideh Gholami, Yasmine Baca, Pavel Brodskiy, Joanne Xiu, Gulam Abbas Manji, Andreas Seeber, Anwaar Saeed, Benjamin Adam Weinberg, Moh'd M. Khushman, Rachna T. Shroff, Jim Abraham, Anthony Frank Shields, Heinz-Josef Lenz, John Marshall, Wolfgang Michael Korn, Emil Lou

Institutions: UC Davis Comprehensive Cancer Center, Caris Life Sciences (United States), Herbert Irving Comprehensive Cancer Center, Innsbruck Medical University, Universität Innsbruck, The University of Kansas Cancer Center, Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, University of Arizona Cancer Center, Wayne State University, The Barbara Ann Karmanos Cancer Institute, University of Southern California, University of Minnesota, Masonic Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4286298403

Cites:

Cited by: 5

Related to: 10